Introduction

The TM Flow test is a novel, non-invasive system that helps physicians in Baton Rouge, LA quickly diagnose many forms of neuropathy. The TM Flow system is highly sensitive at detecting both large fiber and small fiber neuropathies, as well as more than a dozen other conditions. It will help physicians in Baton Rouge, LA find one of the earliest signs of diabetic neuropathy and peripheral arterial disease. The TM Flow system is easy to use and can be performed on an outpatient basis at any accredited laboratory facility in the United States.

The TM Flow system is a novel, non-invasive test for quickly diagnosing the nature and severity of Peripheral Neuropathy.

The TM Flow test is a non-invasive, single-use system that quickly diagnoses the nature and severity of Peripheral Neuropathy. The system is FDA approved and reimbursed by Medicare and many private insurance plans.

It will help physicians in Baton Rouge, LA find one of the earliest signs of diabetic neuropathy and peripheral arterial disease.

TM Flow is a non-invasive test for quickly diagnosing the nature and severity of Peripheral Neuropathy. This includes diabetic neuropathy and peripheral arterial disease, which are both common conditions that affect patients in Baton Rouge, LA.

With TM Flow, physicians in Baton Rouge can find one of the earliest signs of diabetic neuropathy and peripheral arterial disease. In addition to being useful in diagnosing these conditions, it will also help them determine if you have other forms of neuropathy that need attention such as Guillain Barre Syndrome or Carpal Tunnel Syndrome.

The TM Flow system is highly sensitive at detecting both large fiber and small fiber neuropathies, as well as more than a dozen other conditions.

The TM Flow system is highly sensitive at detecting both large fiber and small fiber neuropathies, as well as more than a dozen other conditions. The test can detect many conditions that cause neuropathy, including diabetes and peripheral arterial disease.

TM Flow testing is reimbursable by Medicare and many private insurance plans.

TM Flow testing is reimbursable by Medicare, most private insurance plans, and Medicaid.

• Medicare will reimburse for this test.
• Most private insurance plans will reimburse for this test.
• Medicaid will reimburse for this test.

An easy 15-minute test can diagnose most forms of neuropathy quickly and accurately.

The TM Flow test is a non-invasive, easy 15-minute test that can diagnose most forms of neuropathy quickly and accurately. The test is reimbursable by Medicare and many private insurance plans.

Conclusion

The TM Flow test is a simple and cost-effective way to diagnose many forms of neuropathy quickly and accurately. The test is safe, painless, noninvasive and can be performed in-office with no sedation required. It uses a patient’s own feet as the testing tool instead of needles or electrodes placed on the skin. We are excited about this new test because it will help physicians in Baton Rouge, LA find one of the earliest signs of diabetic neuropathy and peripheral arterial disease so they can begin treatment sooner than ever before!